{"mainPropery":{"diseaseId":6608,"diseaseName":"Primary liver cancer","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6608/primary-liver-cancer","synonyms":["Primary tumor of the liver","Primary Liver Carcinoma","Primary Malignant Liver Neoplasm","Primary cancer of liver","Rare tumor of liver and intrahepatic biliary tract"],"synonyms-with-source":[{"name":"Primary tumor of the liver"},{"name":"Primary Liver Carcinoma","source":"NCI Thesaurus"},{"name":"Primary Malignant Liver Neoplasm","source":"NCI Thesaurus"},{"name":"Primary cancer of liver","source":"NCI Thesaurus"},{"name":"Rare tumor of liver and intrahepatic biliary tract","source":"ORPHANET"}],"identifiers":[]},"diseaseCategories":[{"diseaseTypeId":6,"diseaseTypeName":"Digestive Diseases"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[{"resourceID":120,"resourceName":"American Cancer Society","abbreviation":"","address1":"250 Williams Street NW","address2":"","address3":"","address4":"","address5":"","city":"Atlanta","state":"GA","zip":"30329","country":"United States","phone":"","tty":"","tollFree":"1-800-227-2345","fax":"","email":"","url":"https://www.cancer.org","freeText":""},{"resourceID":942,"resourceName":"American Association for the Study of Liver Diseases","abbreviation":"","address1":"1001 North Fairfax, 4th floor","address2":"","address3":"","address4":"","address5":"","city":"Alexandria","state":"VA","zip":"22314","country":"United States","phone":"703–299–9766","tty":"","tollFree":"","fax":"703–299–9622","email":"aasld@aasld.org","url":"http://www.aasld.org/","freeText":""},{"resourceID":943,"resourceName":"American Liver Foundation","abbreviation":"","address1":"39 Broadway, Suite 2700","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10006","country":"United States","phone":"+1-212-668-1000","tty":"","tollFree":"+1-800-465-4837 (Helpline)","fax":"","email":"https://liverfoundation.org/for-patients/contact-us/","url":"https://liverfoundation.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=114550' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Primary liver cancer. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":710,"resourceId":1405,"resourceName":"NIDDK - Hepatocellular carcinoma","descriptionText":"The National Institute of Diabetes and Digestive and Kidney Diseases, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, Department of Veteran Affairs, and Fogarty International Center sponsored a conference on hepatocellular carcinoma on April 1-3, 2004 to discuss the screening, diagnosis, and management of this type of cancer. You can view the agenda as well as a list of speakers by <a href='http://www.niddk.nih.gov/fund/other/hepato_carc/liver_cancer.pdf ' target='_blank'>clicking here</a>.","resourceClassificationName":"News & Events","resourceClassificationSectionName":"Other Conferences"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/000280.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/282814-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022225' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1543,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='http://www.cancer.gov/cancertopics/pdq/treatment/adult-primary-liver/healthprofessional' target='_blank'>National Cancer Institute</a> provides the most current information on cancer for patients, health professionals, and the general public.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merck.com/mmpe/sec03/ch029/ch029d.html#sec03-ch029-ch029d-586' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1563,"resourceId":2167,"resourceName":"National Kidney and Urologic Diseases Information Clearinghouse","descriptionText":"The <a href='http://www.niddk.nih.gov/fund/other/hepato_carc/liver_cancer.pdf' target='_blank'>National Kidney and Urologic Diseases Information Clearinghouse</a>  (NIDDK) conducts and supports research on a broad spectrum of diseases affecting public health. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:114550' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2163,"resourceId":3372,"resourceName":"Good Days","descriptionText":"<a href='https://www.mygooddays.org/patients/diseases-covered/chronic-iron-overload' target='_blank'>Good Days</a> provides help to patients with life-altering conditions. Assistance includes help with the cost of medications and travel.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":9331,"relatedDiseaseName":"Childhood hepatocellular carcinoma","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":9396,"relatedDiseaseName":"Fibrolamellar carcinoma","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":2657,"relatedDiseaseName":"Hepatoblastoma","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":6042,"relatedDiseaseName":"Intrahepatic cholangiocarcinoma","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":13224,"relatedDiseaseName":"Liver cancer","relation":"Parent","isRare":false,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":753,"genericName":"Cabozantinib","tradeName":"Cabometyx","tradeLink":"https://cabometyx.com/liver-cancer","manufacturer":"","sponsor":"Exelixis, Inc.","indication":"January 2019, cabozantinib (Cabometyx) was approved for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/cabometyx","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a613015.html"},{"productId":730,"genericName":"Lenvatinib","tradeName":"Lenvima","tradeLink":"http://lenvima.com/","manufacturer":"","sponsor":"Eisai Inc.","indication":"August 2018, lenvatimib (Lenvima) was approved for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC).","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/rn/417716-92-8","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a615015.html"},{"productId":597,"genericName":"Ethiodized oil injection","tradeName":"Lipiodol","tradeLink":"http://www.guerbet-us.com/products/contrast-media/lipiodolr-ethiodized-oil-injection.html","manufacturer":"","sponsor":"Guerbet LLC","indication":"September 2013, ethiodized oil injection (Lipiodol) was approved for selective hepatic intra-arterial use for imaging tumors in adults with known hepatocellular carcinoma (HCC).","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/lipiodol","medlinePlusLink":""},{"productId":522,"genericName":"Sorafenib","tradeName":"Nexavar","tradeLink":"http://www.hcp.nexavar-us.com/","manufacturer":"","sponsor":"Bayer Pharmaceutical Corporation","indication":"April 2006, sorafenib (Nexavar) was approved for the treatment of unresectable hepatocellular carcinoma.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/rn/284461-73-0","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a607051.html"},{"productId":678,"genericName":"Regorafenib","tradeName":"Stivarga","tradeLink":"http://www.stivarga-us.com/","manufacturer":"","sponsor":"Bayer HealthCare Pharmaceuticals","indication":"April 2017, regorafenib (Stivarga) was approved for the treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/rn/755037-03-7","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a613004.html"}],"EncodedName":"Primary_liver_cancer"}